MEDICAL ADVOCATES
 IDUs
  HCV National Studies

 Global/Multinational
Africa
Asia
Australia/Pacific Islands
Europe
Latin America/Caribbean
Middle East
 North America
 Russia/NIS
IDU Hepatitis C Main New/Newsworthy  Home Page

Last Update:  April 15, 2018   
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Global/Multinational
 

      Journal Papers, Abstracts, and Commentaries
 
Global, regional, and country-level coverage of interventions to prevent and manage HIV and hepatitis C among people who inject drugs: a systematic review.
Larney S, Peacock A, Leung J, et al
Lancet Glob Health. 2017 Oct 23
 Abstract

FULL-TEXT ARTICLE
Epidemiology of Hepatitis C Virus Among People Who Inject Drugs: Protocol for a Systematic Review and Meta-Analysis
Smith DJ, Neurer J, Jordan AE, Hagan H. J
MIR Res Protoc. 2017 Oct 20;6(10):e201
 Paper

FULL-TEXT PDF ARTICLE
Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013.
Degenhardt L, Charlson F, Stanaway J, et al
Lancet Infect Dis. 2016 Sep 21.
Paper

Global policy and access to new hepatitis C therapies for people who inject drugs.
Doyle JS, Aspinall EJ, Hutchinson SJ, et al
Int J Drug Policy. 2015 Jun 2.
Abstract

An international perspective on using opioid substitution treatment to improve hepatitis C prevention and care for people who inject drugs: Structural barriers and public health potential.
Perlman DC, Jordan AE, Uuskula A,  et al
 Int J Drug Policy. 2015 Apr 27.
 Abstract

Current Burden of Hepatitis C Virus Infection among Injecting Drug Users: A Mini Systematic Review of Prevalence Studies.
Rafiq SM, Banik GR,  et al 
Infect Disord Drug Targets. 2014 Oct 14
 Abstract

Emerging epidemic of hepatitis C infection in young injectors.
Khalsa JH.
Alcohol Alcohol. 2014 Sep;49 Suppl 1:i2.
 Abstract

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews.
Nelson PK, Mathers BM, Cowie B, et al
Lancet. 2011 Aug 13;378(9791):571-83
 Abstract

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs:
results of systematic reviews.
Nelson PK, Mathers BM, Cowie B,  et al
Lancet. 2011 Jul 27.
Abstract
Africa
 
Egypt

     Journal Papers, Abstracts, and Commentaries
 
FULL-TEXT ARTICLE
Injection drug use is a risk factor for HCV infection in urban Egypt.
Jimenez AP, Mohamed MK, Eldin NS, et al 
PLoS One. 2009 Sep 28;4(9):e7193
 Paper
 
Kenya

     Journal Papers, Abstracts, and Commentaries
 
FULL-TEXT ARTICLE
 Serum adiponectin in HIV-1 and hepatitis C virus mono- and co-infected Kenyan injection drug users
 Ndombi EM, Budambula V, Webale MK,  et al
 Endocr Connect. 2015 Aug 25.
Paper
 

       Conference Reports, Abstracts, and Posters

  Hepatitis C virus (HCV) and Human immunodeficiency virus type 1 (HIV-1) co-infection among injecting drug users at the Kenyan coast
R. Mwatelah, W. Ochieng, R. Lwembe, et al
 (XIX International AIDS Conference)
Abstract

Mauritius
 
     Journal Papers, Abstracts, and Commentariess
 
  High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: Findings from a population size estimation
and respondent driven sampling survey.
Johnston L, Saumtally A, Corceal S, et al.
Int J Drug Policy. 20t11 Jul;22(4):252-8.

 Abstract

 
Morocco

     Journal Papers, Abstracts, and Commentaries
 
  Molecular characterization of hepatitis C virus core region in Moroccan intravenous drug users.
Trimbitas RD, Fayssel N, Serghini FZ, et al  "
 J Med Virol. 2016 Jan 11.
 Abstract

 

Senegal

     Conference Reports, Abstracts, and Posters
 
  Interest of dried blood spots (DBS) for genotyping hepatitis C virus among drug users in Senegal (ANRS 12243 UDSEN)
O. Ndiaye, J. Gozlan, H. Diop-Ndiaye et al
 (XIX International AIDS Conference)
 Abstract
 
Tanzania

     Conference Reports, Abstracts, and Posters
 
  Risk factors associated with HCV infection and prevalence of HIV-HCV co-infection among people who inject drugs receiving medication-assisted treatment in Dar es Salaam, Tanzania
O. Chang, R.D. Bruce, F. Masao, et al
 (XX International AIDS Conference)
 Abstract

Australia/Pacific Islands
 
Australia
 
       Journal Papers, Abstracts, and Commentaries
 
 
Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia.
Iversen J, Grebely J, Catlett B,
 Int J Drug Policy. 2017 Jun 1.
Abstract

"Don't think I'm going to leave you over it": Accounts of changing hepatitis C status among couples who inject drugs.
Rance J, Treloar C, Fraser S, Bryant J, Rhodes T.
Drug Alcohol Depend. 2017 Jan 31;173:78-84.
 Abstract

The effects of needle-sharing and opioid substitution therapy on incidence of hepatitis C virus infection and reinfection in people who inject drugs.
Aitken CK, Agius PA, Higgs PG, et al
 Epidemiol Infect. 2016 Dec 8:1-6
 Abstract

Treatment for hepatitis C virus infection among people who inject drugs attending opioid substitution treatment and community health clinics: The ETHOS Study.
Grebely J, Alavi M, Micallef M,  et al
Addiction. 2015 Oct 9.
 Abstract

Understanding decisions made about hepatitis C treatment by couples who inject drugs.
Treloar C, Rance J, Bryant J, Fraser S.
J Viral Hepat. 2015 Aug 25.
Abstract

The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study.
Fortier E, Alavi M, Micallef M,  et al
Int J Drug Policy. 2015 Jun 11
 Abstract

The potential reach of opioid substitution settings to deliver HCV care to people who inject drugs in Australia.
Butler K, Day C, Dietze P, et al
J Subst Abuse Treat. 2015 Jun 17.
Abstract

Opioid substitution therapy is associated with increased detection of hepatitis C virus infection: A 15-year observational cohort study.
Larney S, Grebely J, Falster M, et al
 Drug Alcohol Depend. 2015 Jan 5. pii: S0376-8716(14)02007-9
 Abstract

HIV and Hepatitis C Virus Infection and Risk Behaviors Among Heterosexual, Bisexual, and Lesbian Women Who Inject Drugs in Australia.
Iversen J, Dolan K, Ezard N, Maher L.
 LGBT Health. 2015 Jun;2(2):127-134.
 Abstract

FULL-TEXT PDF ARTICLE
 Incidence and correlates of hepatitis C virus infection in a large cohort of prisoners who have injected drugs
 Snow KJ, Young JT, Preen DB,  et al
BMC Public Health. 2014 Aug 11;14(1):830.
Paper

Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011.
Iversen J, Grebely J, Topp L,  et al
J Viral Hepat. 2014 Mar;21(3):198-207.
Abstract

Peer support models for people with a history of injecting drug use undertaking assessment and treatment for hepatitis C virus infection.
 Crawford S, Bath N.
 Clin Infect Dis. 2013 Aug;57 Suppl 2:S75-9.
Abstract

Assessment and Treatment of Hepatitis C Virus Infection Among People Who Inject Drugs in the Opioid Substitution Setting: ETHOS Study.
Alavi M, Grebely J, Micallef M, et al
Clin Infect Dis. 2013 Aug;57 Suppl 2:S62-9
 Abstract

FULL-TEXT ARTICLE
 Hepatitis C virus phylogenetic clustering is associated with the social-injecting network in a cohort of people who inject drugs.
 Sacks-Davis R, Daraganova G, Aitken C, et al
PLoS One. 2012;7(10):e47335.
Paper

Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
Treloar C, Hull P, Dore GJ, Grebely J.
Drug Alcohol Rev. 2012 May 21.
Abstract

Modelling hepatitis C transmission over a social network of injecting drug users.
Rolls DA, Daraganova G, Sacks-Davis R,  et al
J Theor Biol. 2011 Dec 16
 Abstract

Frequent multiple hepatitis C virus infections among injection drug users in a prison setting.
Pham ST, Bull RA, Bennett JM,  et al
 Hepatology. 2010 Nov;52(5):1564-72
 Abstract

"Fitness for duty": Social, organisational and structural influences on the design and conduct
of candidate hepatitis C vaccine trials involving people who inject drugs.
Treloar C, Byron P, McCann P, Maher L.
Vaccine. 2010 Jun 7
 Abstract

Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people
who inject drugs in Australia 1998-2008.
Iversen J, Wand H, Gonnermann A, Maher L;  et al  
Int J Drug Policy. 2010 May 14.
 Abstract

Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not
enrolled in methadone maintenance programs.
Zeiler I, Langlands T, Murray JM, Ritter A.
Drug Alcohol Depend. 2010 Apr 27.
 Abstract

Establishment of a successful assessment and treatment service for
Australian prison inmates with chronic hepatitis C.
Boonwaat L, Haber PS, Levy MH, Lloyd AR.
Med J Aust. 2010 May 3;192(9):496-500.
 Abstract
 
 
          Conference Reports, Abstracts, and Posters
 
  Low rates of re-infection and reduced injecting long-term following recently acquired HCV in the Australian trial of acute hepatitis C: the ATAHC recall study
J.S. Doyle, D. Shaw, G.J. Doe, et al
 (XX International AIDS Conference)
 Abstract

Philippines

           Journal Papers, Abstracts, and Commentaries
 
  Rapid spread of hepatitis C virus among injecting-drug users in the Philippines:
Implications for HIV epidemics.
Agdamag DM, Kageyama S, Alesna ET, et al
J Med Virol. 2005 Aug 24;77(2):221-226
Abstract
Latin America/Caribbean
       
Brazil

          Journal Papers, Abstracts, and Commentaries
 
 
FULL-TEXT ARTICLE
 The progression of liver fibrosis in prison inmates co-infected by HIV and HCV who started on boosted protease inhibitor therapy]
Saiz de la Hoya Zamácola P, Alía Alía C,  et al
Rev Esp Sanid Penit. 2013 Oct;15(2):54-62.
Paper
 
Columbia

          Journal Papers, Abstracts, and Commentaries

  Hepatitis C and HIV in injecting drug users in Armenia, Colombia.
Berbesi-Fernández D, Segura-Cardona Á, Montoya-Vélez L, Castaño-Perez GA.
Adicciones. 2015 Dec 15;27(4):246-252.
Abstract

Mexico

           Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.
 Silverman-Retana O, Serván-Mori E, McCoy SI, Larney S, Bautista-Arredondo S. 
Drug Alcohol Depend. 2017 Oct 14
 Abstract

FULL TEXT ARTICLE
Prevalence of hepatitis C virus and HIV infection among injection drug users in two Mexican
cities bordering the U.S.
White EF, Garfein RS, Brouwer KC, et al
Salud Publica Mex. 2007 May-Jun;49(3):165-72.
Paper
 
Puerto Rico

          Journal Papers, Abstracts, and Commentaries

  Injection Partners, HCV, and HIV Status among Rural Persons Who Inject Drugs in Puerto Rico.
Habecker P, Abadie R, Welch-Lazoritz M, et al
Subst Use Misuse. 2017 Nov 22:1-11.
Abstract

FULL-TEXT ARTICLE
Understanding differences in HIV/HCV prevalence according to differentiated risk behaviors in a sample of PWID in rural Puerto Rico
 Abadie R, Welch-Lazoritz M, Gelpi-Acosta C, et al
Harm Reduct J. 2016 Mar 8;13(1):10. 
Paper

Prevalence and Correlates of Hepatitis C Virus Infection among Street-Recruited Injection Drug
Users in San Juan, Puerto Rico.
Reyes JC, Colon HM, Robles RR, et al
J Urban Health. 2006 Oct 31;
 Abstract
 
Middle East
 		      
Afghanistan

          Journal Papers, Abstracts, and Commentaries

 
FULL-TEXT PDF ARTICLE
 Prevalence and correlates of HIV, syphilis, and hepatitis B and C infection and harm reduction program
use among male injecting drug users in Kabul, Afghanistan: A cross-sectional assessment.
Todd CS, Nasir A, Stanekzai MR, et al 
Harm Reduct J. 2011 Aug 25;8(1):22.
Paper

Implications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users
 in three Afghan cities.
Nasir A, Todd CS, Stanekzai MR,  et al
Int J Infect Dis. 2010 Dec 27.
 Abstract

Iran

          Journal Papers, Abstracts, and Commentaries
 
  Comparing Characteristics of Early-Onset Injection Drug Users to Those With Late-Onset Injection in Kermanshah, Iran.
Jojaran Shushtari Z, Noroozi A, et al  
Subst Use Misuse. 2017 Feb 3
 Abstract

HCV, HBV, and HIV seroprevalence, coinfections, and related behaviors among male injection drug users in Arak, Iran.
Ramezani A, Amirmoezi R, Volk JE, et al   
AIDS Care. 2014 Feb 6.
Abstract

Molecular epidemiology of hepatitis C virus among injection drug users in Iran: a slight change in prevalence of HCV genotypes over time.
Samimi-Rad K, Nasiri Toosi M, Masoudi-Nejad A,  et al
Arch Virol. 2012 Jun 13.
Abstract

FULL-TEXT ARTICLE
Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran.
Kassaian N, Adibi P, Kafashaian A,  et al
 Int J Prev Med. 2012 Mar;3(Suppl1):S156-S16
 Paper

FULL-TEXT ARTICLE
Seroprevalence and Risk Factors of Hepatitis C Virus among Juveniles in Correctional Center in Isfahan, Iran.
Nokhodian Z, Ataei B, Kassaian N,  et al
 Int J Prev Med. 2012 Mar;3(Suppl1):S113-S117.
 Paper
   
Lebanon
 
          Journal Papers, Abstracts, and Commentaries
 
  Distribution of hepatitis C virus genotypes among injecting drug users in Lebanon.
Mahfoud Z, Kassak K, Kreidieh K, et al
Virol J. 2010 May 13;7(1):9
Abstract
Russia/New Independent States
 		      
Multinational
 
          Journal Papers, Abstracts, and Commentaries
 
  Measuring risk of HIV and HCV among injecting drug users in the Russian Federation.
Platt L, Sutton AJ, Vickerman P, et al  
Eur J Public Health. 2009 Apr 5.
Abstract
 
Bulgaria

          Journal Papers, Abstracts, and Commentaries

  Needle exchange use, sexual risk behaviour, and the prevalence of HIV, hepatitis B virus,
and hepatitis C virus infons among Bulgarian injection drug users.
Vassilev ZP, Hagan H, Lyubenova A, Tomov N, et al
Int J STD AIDS. 2006 Sep;17(9):621-6.
 Abstract
 

Russia

          Journal Papers, Abstracts, and Commentaries
 
 
Taking care of themselves: how long-term injection drug users remain HIV and Hepatitis C free.
Meylakhs P, Friedman SR, Mateu-Gelabert P, .et al 
Sociol Health Illn. 2015 Feb 16.
Abstract

FULL-TEXT ARTICLE
Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities.
Heimer R, Eritsyan K, Barbour R, Levina OS.
BMC Infect Dis. 2014 Sep 19;14(Suppl 6):S12.
 Paper

Ukraine
 
      Journal Papers, Abstracts, and Commentaries
 
  Hepatitis C virus status awareness and test results confirmation among people who inject drugs in Ukraine.
 Iakunchykova O, Meteliuk A, Zelenev A, et al  
Int J Drug Policy. 2018 Apr 11;57:11
 Abstract

Implementing and scaling up HCV treatment services for people who inject drugs and other high risk groups in Ukraine: An evaluation of programmatic and treatment outcomes.
Mazhnaya A, Meteliuk A, Barnard T, et al
Int J Drug Policy. 2017 Aug 12
 Abstract

HIV and hepatitis C virus infections among hanka injection drug users in central Ukraine:
a cross-sectional survey.
Dumchev KV, Soldyshev R, Qian HZ, et al
Harm Reduct J. 2009 Aug 23;6(1):23
 Abstract

IDU Hepatitis C Main New/Newsworthy  Home Page

IDU Hepatitis C National Studies